Hypoxia-activated prodrugs and redox-responsive nanocarriers

Hypoxia is one of the marked features of malignant tumors, which is associated with several adaptation changes in the microenvironment of tumor cells. Therefore, targeting tumor hypoxia is a research hotspot for cancer therapy. In this review, we summarize the developing chemotherapeutic drugs for t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Nanomedicine
Asıl Yazarlar: Zeng, Yun, Ma, Jingwen, Zhan, Yonghua, Xu, Xinyi, Zeng, Qi, Liang, Jimin, Chen, Xueli
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6202002/
https://ncbi.nlm.nih.gov/pubmed/30425475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S173431
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller